desoxycorticosterone has been researched along with opc 21268 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K; Hashimoto, M; Mimura, Y; Ogura, T; Oishi, T; Ota, Z; Otsuka, F; Yamauchi, T | 1 |
| Kanno, Y; Okada, H; Saruta, T; Suzuki, H | 1 |
| Akishita, M; Liang, J; Orimo, H; Ouchi, Y; Toba, K | 1 |
| Burrell, LM; Johnston, CI; Phillips, PA; Risvanis, J; Rolls, KA; Stephenson, JM | 1 |
| Goto, A; Hayakawa, H; Hirata, Y; Hirobe, M; Kakoki, M; Kikuchi, K; Kimura, K; Nagano, T; Nagata, D; Omata, M; Suzuki, E; Tojo, A | 1 |
| He, G; Intengan, HD; Schiffrin, EL | 1 |
6 other study(ies) available for desoxycorticosterone and opc 21268
| Article | Year |
|---|---|
Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats.
Topics: Animals; Benzazepines; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Heart Rate; Male; Piperidines; Quinolones; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Vasopressin; Time Factors | 1995 |
Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Body Weight; Desoxycorticosterone; Hypertension; Male; Piperidines; Quinolones; Random Allocation; Rats; Rats, Wistar; Sodium Chloride | 1995 |
Effect of an intracerebroventricularly administered vasopressin V1 antagonist on blood pressure and heart rate in deoxycorticosterone-salt hypertensive rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Cardiac Output; Desoxycorticosterone; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Injections, Intravenous; Injections, Intraventricular; Male; Microdialysis; Piperidines; Quinolones; Rats; Rats, Wistar | 1994 |
Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding Sites; Blood Pressure; Desoxycorticosterone; Female; Hypertension; Kinetics; Mesenteric Arteries; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium Chloride; Systole; Vascular Resistance | 1994 |
Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Agents | 1997 |
Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Biomechanical Phenomena; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Elasticity; Endothelin-1; Gene Expression; Hypertension; Male; Mesenteric Artery, Superior; Nephrectomy; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Vasodilation | 1998 |